Observational studyMedicine2025

Prognostic differences in patients with advanced solid tumors receiving immune checkpoint inhibitors: The role of immune-related adverse events.

Cheng Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.